NovaBay Pharma (NBY) - Analyst Ratings

NovaBay Pharma (NBY) – Analyst Ratings

May 20, 2022 07:00 AM NovaBay Pharmaceuticals (NBY) Reports In-Line with Strong Guidance, PT Lowered to $4 at Ascendiant Capital
Sep 18, 2019 06:41 AM Ladenburg Thalmann Starts NovaBay Pharmaceuticals (NBY) at Buy
Mar 13, 2019 01:53 PM
Mar 13, 2019 07:43 AM
Nov 16, 2018 02:34 PM
Jul 6, 2018 07:59 AM
Mar 26, 2018 08:29 AM
Jun 5, 2017 07:14 AM
Mar 28, 2017 04:03 AM
Mar 24, 2017 07:58 AM
Mar 7, 2016 12:57 PM
Apr 29, 2015 05:00 PM
Mar 6, 2013 08:01 AM
Apr 12, 2012 01:16 PM
Sep 16, 2011 08:33 AM
Jul 24, 2008 09:42 AM
Jun 6, 2006 07:39 AM
May 15, 2006 07:36 AM